Free Trial

Enliven Therapeutics (ELVN) Institutional Ownership

Enliven Therapeutics logo
$20.01 +1.44 (+7.75%)
Closing price 09/26/2025 04:00 PM Eastern
Extended Trading
$19.98 -0.03 (-0.17%)
As of 09/26/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Enliven Therapeutics (NASDAQ:ELVN)

Current
Institutional Ownership
Percentage
95.08%
Number of
Institutional Buyers
(last 12 months)
66
Total
Institutional Inflows
(last 12 months)
$207.52M
Number of
Institutional Sellers
(last 12 months)
38
Total
Institutional Outflows
(last 12 months)
$90.81M
Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Tower Research Capital LLC TRC 5,286$106K0.0%+194.3%0.009%
8/15/2025 Duquesne Family Office LLC463,000$9.29M0.2%N/A0.782%
8/15/2025 BNP Paribas Financial Markets3,722$75K0.0%+33.3%0.008%
8/15/2025 Bank of America Corp DE24,508$492K0.0%+20.0%0.050%
8/15/2025 5AM Venture Management LLC772,477$15.50M6.0%-41.6%1.574%
8/15/2025 Adage Capital Partners GP L.L.C.96,000$1.93M0.0%-78.7%0.196%
8/15/2025 Ameriprise Financial Inc.59,244$1.19M0.0%+150.4%0.121%
8/14/2025 Commodore Capital LP4,692,809$94.14M6.6%+0.4%9.563%
8/14/2025 TCG Crossover Management LLC498,000$9.99M1.1%N/A1.015%
8/14/2025 Jane Street Group LLC56,981$1.14M0.0%+94.1%0.116%
8/14/2025 California State Teachers Retirement System20,330$408K0.0%-2.8%0.041%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,656$354K0.0%-18.7%0.036%
8/14/2025 The Manufacturers Life Insurance Company 44,151$886K0.0%+242.4%0.090%
8/14/2025 HighVista Strategies LLC141,516$2.84M1.0%+25.8%0.288%
8/14/2025 Federated Hermes Inc.16,098$323K0.0%-76.7%0.033%
8/13/2025 Affinity Asset Advisors LLC400,000$8.02M1.1%N/A0.815%
8/13/2025 Tema Etfs LLC32,579$654K0.2%+37.8%0.066%
8/13/2025 Marshall Wace LLP333,333$6.69M0.0%+2,886.9%0.679%
8/13/2025 Invesco Ltd.21,957$440K0.0%+4.3%0.045%
8/13/2025 Quantbot Technologies LP4,477$90K0.0%+47.1%0.009%
8/13/2025 Virtus Investment Advisers LLC4,783$96K0.0%-33.0%0.010%
8/13/2025 Russell Investments Group Ltd.29,547$593K0.0%-72.0%0.060%
8/12/2025 XTX Topco Ltd11,362$228K0.0%-48.0%0.023%
8/12/2025 Rhumbline Advisers50,280$1.01M0.0%-4.2%0.102%
8/12/2025 Franklin Resources Inc.430,240$8.63M0.0%+2,029.3%0.877%
8/12/2025 Legal & General Group Plc32,225$646K0.0%+52.2%0.066%
8/12/2025 JPMorgan Chase & Co.19,064$382K0.0%-12.4%0.039%
8/12/2025 Swiss National Bank61,873$1.24M0.0%+47.8%0.126%
8/11/2025 Patient Square Capital LP245,838$4.93M1.8%-3.2%0.501%
8/8/2025 Intech Investment Management LLC14,502$291K0.0%-27.9%0.030%
8/8/2025 SG Americas Securities LLC36,373$730K0.0%+177.4%0.074%
8/8/2025 Candriam S.C.A.416,650$8.36M0.0%N/A0.849%
8/8/2025 Geode Capital Management LLC882,753$17.71M0.0%+7.8%1.799%
7/28/2025 TD Asset Management Inc66,906$1.34M0.0%N/A0.136%
7/23/2025 KLP Kapitalforvaltning AS6,800$136K0.0%+58.1%0.014%
6/27/2025 Goldman Sachs Group Inc.211,752$4.17M0.0%+61.3%0.432%
5/29/2025Rhumbline Advisers52,502$1.03M0.0%+4.9%0.107%
5/19/2025Jane Street Group LLC29,351$578K0.0%N/A0.060%
5/16/2025Woodline Partners LP805,157$15.85M0.1%-0.1%1.641%
5/16/2025Goldman Sachs Group Inc.211,752$4.17M0.0%+61.3%0.432%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.21,729$428K0.0%+8.4%0.044%
5/16/2025Ally Bridge Group NY LLC169,774$3.34M3.0%+19.8%0.346%
5/16/20255AM Venture Management LLC1,322,477$26.03M9.8%-18.9%2.695%
5/16/2025Adage Capital Partners GP L.L.C.450,000$8.86M0.0%-30.8%0.917%
5/15/2025Tema Etfs LLC23,648$465K0.1%N/A0.048%
5/14/2025Quantbot Technologies LP3,043$60K0.0%N/A0.006%
5/14/2025Wellington Management Group LLP84,700$1.67M0.0%+4.7%0.173%
5/13/2025Lord Abbett & CO. LLC197,279$3.88M0.0%-48.9%0.402%
5/13/2025Russell Investments Group Ltd.105,542$2.08M0.0%+148,550.7%0.215%
5/12/2025Nuveen LLC104,099$2.05M0.0%N/A0.212%
5/12/2025Invesco Ltd.21,044$414K0.0%+39.6%0.043%
5/9/2025Deutsche Bank AG27,524$542K0.0%-9.8%0.056%
5/9/2025Charles Schwab Investment Management Inc.259,537$5.11M0.0%-0.9%0.529%
5/9/2025Vanguard Group Inc.1,972,239$38.81M0.0%-0.2%4.020%
5/9/2025BIT Capital GmbH19,386$382K0.0%N/A0.040%
5/8/2025XTX Topco Ltd21,849$430K0.0%N/A0.045%
5/8/2025Federated Hermes Inc.69,051$1.36M0.0%-41.3%0.141%
5/1/2025New York State Common Retirement Fund9,797$193K0.0%-60.8%0.020%
4/30/2025China Universal Asset Management Co. Ltd.9,800$193K0.0%-5.4%0.020%
4/29/2025Bank of New York Mellon Corp93,567$1.84M0.0%+4.5%0.191%
4/17/2025Exchange Traded Concepts LLC6,055$119K0.0%-19.1%0.012%
4/8/2025Rhumbline Advisers52,502$1.03M0.0%+4.9%0.107%
4/7/2025GAMMA Investing LLC2,716$53K0.0%+3,058.1%0.006%
3/24/2025Wellington Management Group LLP80,916$1.82M0.0%+15.3%0.165%
3/18/2025California State Teachers Retirement System20,914$471K0.0%+10.2%0.043%
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC43,714$984K0.0%+67.1%0.089%
2/17/2025Soleus Capital Management L.P.75,405$1.70M0.1%-68.5%0.154%
2/17/2025Two Sigma Investments LP14,620$329K0.0%-33.8%0.030%
2/17/2025Stempoint Capital LP96,716$2.18M0.5%N/A0.198%
2/17/2025Polar Capital Holdings Plc2,389,668$53.77M0.3%+267.6%4.891%
2/17/2025ProShare Advisors LLC12,229$275K0.0%+29.5%0.025%
2/17/2025Patient Square Capital LP224,038$5.04M1.9%+147.4%0.459%
2/17/2025Nicholas Investment Partners LP157,635$3.55M0.3%-9.3%0.323%
2/17/2025Millennium Management LLC50,804$1.14M0.0%+108.6%0.104%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,036$451K0.0%+3.7%0.041%
2/17/2025Janus Henderson Group PLC1,331,877$30.00M0.0%+27.9%2.726%
2/17/2025Graham Capital Management L.P.15,178$342K0.0%+67.3%0.031%
2/17/2025Deutsche Bank AG30,516$687K0.0%+51.7%0.062%
2/17/2025Brevan Howard Capital Management LP10,144$228K0.0%N/A0.021%
2/17/2025Bank of America Corp DE34,187$769K0.0%-29.8%0.070%
2/17/2025BNP Paribas Financial Markets4,991$112K0.0%N/A0.010%
2/17/2025Ameriprise Financial Inc.35,059$789K0.0%N/A0.072%
2/17/2025Ally Bridge Group NY LLC141,710$3.19M2.7%-39.7%0.290%
2/17/20255AM Venture Management LLC1,629,765$36.67M8.8%-7.0%3.336%
2/17/2025Acuta Capital Partners LLC267,368$6.02M6.1%-9.8%0.547%
2/14/2025Boxer Capital Management LLC671,358$15.11M1.3%N/A1.374%
2/14/2025RA Capital Management L.P.848,986$19.10M0.3%-20.0%1.738%
2/14/2025Northern Trust Corp331,500$7.46M0.0%+8.9%0.678%
2/14/2025Artia Global Partners LP102,900$2.32M0.8%N/A0.211%
2/14/2025Boothbay Fund Management LLC104,890$2.36M0.1%-21.0%0.215%
2/14/2025Virtus ETF Advisers LLC3,091$70K0.0%-26.2%0.006%
2/14/2025Lord Abbett & CO. LLC386,211$8.69M0.0%+20.3%0.790%
2/14/2025Voya Investment Management LLC10,702$241K0.0%-8.1%0.022%
2/14/2025Adage Capital Partners GP L.L.C.650,000$14.63M0.0%-18.8%1.330%
2/14/2025Price T Rowe Associates Inc. MD13,627$307K0.0%+17.0%0.028%
2/14/2025Tower Research Capital LLC TRC1,598$36K0.0%+230.2%0.003%
2/14/2025MetLife Investment Management LLC21,746$489K0.0%+6.3%0.045%
2/13/2025Marshall Wace LLP41,382$931K0.0%-70.0%0.085%
2/13/2025Barclays PLC64,563$1.45M0.0%+14.8%0.132%
2/13/2025Legal & General Group Plc21,140$476K0.0%-2.9%0.043%
(Data available from 1/1/2016 forward)

ELVN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELVN shares?

During the previous two years, 93 institutional investors and hedge funds held shares of Enliven Therapeutics. The most heavily invested institutionals were FMR LLC ($146.16M), Commodore Capital LP ($94.14M), Polar Capital Holdings Plc ($53.77M), Vanguard Group Inc. ($38.81M), Janus Henderson Group PLC ($30.00M), Pictet Asset Management Holding SA ($21.88M), and RA Capital Management L.P. ($19.10M).Learn more on Enliven Therapeutics' institutional investors.

What percentage of Enliven Therapeutics' stock is owned by institutional investors?

95.08% of Enliven Therapeutics' stock is owned by institutional investors. Learn more on ELVN's institutional investor holdings.

Which institutional investors have been buying Enliven Therapeutics' stock?

Of the 74 institutional investors that purchased Enliven Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Polar Capital Holdings Plc ($1.74M), Janus Henderson Group PLC ($908.57K), FMR LLC ($801.30K), Boxer Capital Management LLC ($671.36K), First Turn Management LLC ($535.09K), Marshall Wace LLP ($514.27K), and TCG Crossover Management LLC ($498K).

How much institutional buying is happening at Enliven Therapeutics?

Institutional investors have bought a total of 9,316,124 shares in the last 24 months. This purchase volume represents approximately $207.52M in transactions.

Which of Enliven Therapeutics' major shareholders have been selling company stock?

Of the 38 institutional investors that sold Enliven Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($1.27M), 5AM Venture Management LLC ($979.70K), Adage Capital Partners GP L.L.C. ($704K), Lord Abbett & CO. LLC ($188.93K), Soleus Capital Management L.P. ($164.30K), Acuta Capital Partners LLC ($130.33K), and Federated Hermes Inc. ($101.45K).

How much institutional selling is happening at Enliven Therapeutics?

Institutional investors have sold a total of 4,074,071 shares in the last 24 months. This volume of shares sold represents approximately $90.81M in transactions.



This page (NASDAQ:ELVN) was last updated on 9/27/2025 by MarketBeat.com Staff
From Our Partners